MANKIND PHARMA
Back to Balance Sheet
|
MANKIND PHARMA Last 5 Year Total Debt History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Debt | ₹196 Cr | ₹163 Cr | ₹868 Cr | ₹235 Cr | ₹128 Cr |
What is the latest Total Debt ratio of MANKIND PHARMA ?
Year | Total Debt |
---|---|
Mar2024 | ₹196 Cr |
Mar2023 | ₹163 Cr |
Mar2022 | ₹868 Cr |
Mar2021 | ₹235 Cr |
Mar2020 | ₹128 Cr |
How is Total Debt of MANKIND PHARMA Trending?
Years | Total Debt | % Change | |
---|---|---|---|
Mar2024 | ₹196 Cr | 20.54 | |
Mar2023 | ₹163 Cr | -81.26 | |
Mar2022 | ₹868 Cr | 270.12 | |
Mar2021 | ₹235 Cr | 83.15 | |
Mar2020 | ₹128 Cr | - |
Compare Total Debt of peers of MANKIND PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
MANKIND PHARMA | ₹98,473.2 Cr | -1.4% | -6.9% | 5.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹408,259.0 Cr | 0.5% | -3.4% | 13.4% | Stock Analytics | |
DIVIS LABORATORIES | ₹154,917.0 Cr | -2.2% | 0.3% | 58.8% | Stock Analytics | |
CIPLA | ₹119,705.0 Cr | 2.2% | 3.9% | 2.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹99,953.9 Cr | -1.5% | -7% | -5% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹91,889.3 Cr | -2.3% | -7.4% | 3.7% | Stock Analytics |
MANKIND PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
MANKIND PHARMA | -1.4% |
-6.9% |
5.9% |
SENSEX | -0.4% |
-1.4% |
5.4% |
You may also like the below Video Courses